ArticleSkeletal radiology2013
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
Article in Skeletal radiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 34 citations in OpenAlex.
- Article
- Unveiling the Rare: A Case Report of Rectal Schwannoma in a Neurofibromatosis Type 1 Patient.Cureus · 2025Article
- Clinical Features and Ultrasonographic Manifestations of Retroperitoneal Nerve Sheath Tumors.Current medical imaging · 2025Article
- Recurrence of spinal schwannomas in a patient with neurofibromatosis type 1: a case report.Annals of medicine and surgery (2012) · 2024Article
- New insights into the evaluation of peripheral nerves lesions: a survival guide for beginners.Neuroradiology · 2022Review
- Schwannoma and Neurofibroma, Originating from the Ulnar Nerve in Neurofibromatosis: A Case Report and Review of the Literature.Surgery journal (New York, N.Y.) · 2020Article
- C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.International journal of molecular sciences · 2020Article
- Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017Review
- Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.Journal of magnetic resonance imaging : JMRI · 2016Article
- Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.Skeletal radiology · 2016Article
- Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience.AJNR. American journal of neuroradiology · 2014Article
- fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies.Current oncology (Toronto, Ont.) · 2014Article
- Intraosseous schwannoma in schwannomatosis.Skeletal radiology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Neurofibromatosis type 1 (NF1) is a neurocutaneous syndrome characterized by the development of multiple peripheral nerve sheath tumors, the majority of which are benign neurofibromas. However, malignant peripheral nerve sheath tumors (MPNSTs) occur with a 10 % lifetime risk in patients with NF1, often developing within a neurofibroma. When clinical suspicion for an MPNST arises, imaging with FDG PET and MRI is performed to characterize a peripheral tumor for potential malignancy. In this report, we describe a patient with NF-1 who had two peripheral tumors with similar features by PET, both suspicious for MPNST, but differing features by MRI, one of which was subsequently determined to be an MPNST and the second to be a schwannoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.